p53 Expression and p53 Gene Mutation in Oral Cancer and Dysplasia

Abstract

BACKGROUND: The aim of the current study was to examine the possible association of the p53 tumor suppressor gene with the development of oral cancer. We examined biopsy material from patients with oral squamous cell carcinoma for p53 protein expression and p53 mutations.

METHODS: Eighteen samples were analyzed. These comprised oral squamous cell carcinoma biopsy samples and oral dysplastic biopsy material taken from nine patients. An immunohistochemical technique was used to determine p53 protein expression. A direct sequencing technique was used to detect mutations in the p53 gene itself.

RESULTS: Overall seven of nine (77%) oral squamous cell carcinomas and seven of nine (77%) oral dysplastic lesions analyzed showed evidence of p53 protein over-expression. Mutations in exons 5 and 6 of the p53 gene were detected in five of nine (55%) oral squamous cell carcinomas and four of nine (44%) dysplastic lesions analyzed.

CONCLUSIONS: Both p53 protein over-expression and p53 mutations were noted in dysplastic oral lesions. Over-expression of the p53 protein and p53 gene mutations were not always coexistent, however, suggesting that gene mutation may be only one of the mechanisms responsible for stabilization of the p53 protein.

Get full access to this article

View all access options for this article.

References

Gluckman

Savoury

Carcinoma of the oral cavity. In: Paparella

Shumrick

Gluckman

Meyerhoff

, eds. Otolaryngology volume 3. 3rd ed. Philadelphia: WB Saunders; 1999. p. 2041–69

McBride

Merry

Givol

The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13)

Pro Nat Acad Sci U S A 1986 83:130–4

Chang

Syrjanen

Tervahauta

Syrjanen

Tumourigenesis associated with the p53 tumour suppressor gene

Br J Cancer 1993 68:653–61

Burns

Baird

Clark

. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines Br J Cancer 1993 67:1274–84

Lane

Crawford

T antigen is bound to a host protein in SV40-transformed cells. Nature 1979 278:261

Gannon

Greaves

Iggo

Lane

Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form

Journal of the European Molecular Biology Organisation 1990 9:1595–602

Wynford-Thomas

p53 in tumour pathology: Can we trust immunocytochemistry?

J Pathol 1992 166:329–30

Pinhasi

Michaloivitz

Ben

Oren

Specific interaction between the p53 cellular tumour antigen and major heat shock proteins

Nature 1986 320:182–4

Lewensohn-Fuchs

Munck-Wikland

Berke

. Involvement of aberrant p53 expression and human papillomavirus in carcinoma of the head, neck and esophagus. Anticancer Res 1994 14(3B):1281–5

10.

O'Rouke

Miller

Kato

. A potential transcriptional activation element in the p53 protein Oncogene 1990 5:1829–32

11.

Purdie

O'Grady

Piris

Wyllie

Bird

p53 expression in colorectal tumors. Am J Pathol 1991 138(4):807–13

12.

Hollstein

Sidransky

Vogelstein

Harris

p53 mutations in human cancers

Science 1991 253:49–53

13.

Nylander

Nilsson

Mehle

Roos

p53 mutations, protein expression and cell proliferation in squamous cell carcinomas of the head and neck

Br J Cancer 1995 71:826–30

14.

Greenblatt

Bennett

Hollstein

Harris

Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis

Cancer Res 1994 54:4855–78

15.

Hollstein

Rice

Greenblatt

. Database of p53 gene somatic mutations in human tumors and cell lines. Nucleic Acids Res 1994 22(17):3551–5

16.

Somers

Merrick

Lopez

Incognito

Schechter

Casey

Frequent p53 mutations in head and neck cancer

Cancer Res 1992 52:5997–6000

17.

Brennan

Boyle

Koch

. Association between cigarette smoking and mutation of the p53 gene in squamous cell carcinoma of the head and neck N Engl J Med 1995 332:712–7

18.

Bennett

Hollstein

Metcalf

. p53 mutation and protein accumulation during multistage human esophageal carcinogenesis Cancer Res 1992 52:6092–7

19.

Sundaresan

Ganly

Hasleton

. p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus Oncogene 1992 7:1989–97

20.

Wood

Medina

Thompson

Houck

Min

K-W

Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia

Otolaryngol Head Neck Surg 1994 111:758–63

21.

Hsu

Raine

Fanger

Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem 1981 29:577

22.

Shi

S-R

Key

Kalra

Antigen retrieval in formalin-fixed, paraffin embedded tissues: An enhancement method for immunohistochemical staining based upon microwave oven heating of tissue sections

J Histochem Cytochem 1991 39:741–8

23.

Sanger

Nicklen

Coulson

DNA sequencing with chain terminating inhibitors. Proc Nat Acad Sci U S A 1977 74(12):5463–7

24.

Maestro

Dolcetti

Gasparotto

. High frequency of p53 gene alterations associated with protein overexpression in human squamous cell carcinoma of the larynx. Oncogene 1992 7:1159–65

25.

Chen

Huvos

. Overexpression of 053 protein in squamous cell carcinoma of head and neck without apparent gene mutation. Diagn Mol Pathol 1994 3(2):83–92

26.

Werness

Levine

Howley

The E6 proteins encoded by human papillomavirus types 16 and 18 can complex p53 in vitro

Science 1990 248:76–9

27.

Gusterson

Anbazhagan

Warren

. Expression of p53 in premalignant and malignant squamous epithelium Oncogene 1991 6:1785–9

28.

Fisher

Gillett

Vojtesek

Barnes

Millis

Problems with p53 immunohistochemical staining: The effect of fixation and variation in the methods of evaluation

Br J Cancer 1994 69:26–31